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Introduction: Aeromonas hydrophila sometimes causes bacteremia, which can be fatal in compromised patients,
such as those with liver cirrhosis. We present a case of septic shock due to Aeromonas hydrophila bacteremia in a
patient with liver cirrhosis, which was successfully treated with rapid resuscitation and critical care.
Case presentation: A 71-year-old Japanese man with liver cirrhosis was transported to our emergency center by
ambulance after presenting with gait difficulties and fever. On arrival, he exhibited shock and severe lactic acidosis,
which was suggestive of sepsis, and was immediately resuscitated and administered empiric antibiotic therapy. He
also displayed catecholamine-resistant hypotension, which was successfully treated with critical care including
supportive therapies, such as polymyxin B hemoperfusion and cytokine-absorbing hemofiltration. Aeromonas
hydrophila was detected in his initial blood cultures.
Conclusions: Aeromonas septicemia should be considered in patients with alcoholic liver cirrhosis who have
profound shock. In addition to goal-directed therapy and the prompt administration of empiric antibiotic therapy,
aggressive critical care involving multiple supportive therapies can save such patients.
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Aeromonas species cause a wide spectrum of diseases such
as gastroenteritis, wound infections, and septicemia. Diar-
rheal disease is the most common type of condition asso-
ciated with Aeromonas infection. Penetrating or abrasive
injuries that occur in an aquatic environment or in soil
can lead to mild to severe infections, which present with
cellulitis, myonecrosis, and ecthyma gangrenosum.
Aeromonas septicemia is strongly associated with immu-
nocompromising conditions such as hematological ma-
lignancies and serious hepatobiliary disease. Among the
various Aeromonas species, Aeromonas hydrophila (A.
hydrophila) is the most commonly identified pathogen
[1,2]. Cirrhotic patients are immunocompromised and,
hence, exhibit significant bacterial infection-associated
morbidity and mortality rates (approximately 30%) [3].* Correspondence: tyumoto@cc.okayama-u.ac.jp
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unless otherwise stated.When a patient develops septic shock, early goal-directed
therapy and effective antibiotic treatment should be pro-
vided within the first hour of documented hypotension to
increase their chances of survival [4,5]. We describe a case
of septic shock due to A. hydrophila bacteremia in a cir-
rhotic patient, which was successfully treated with imme-
diate antimicrobial administration and multiple supportive
therapies including endotoxin absorption and cytokine-
absorbing hemofiltration.Case presentation
A 71-year-old Japanese man complaining of gait difficul-
ties and fever was brought to our emergency and critical
care medical center by ambulance. He had had general
fatigue for several days before admission. He had alco-
holic liver cirrhosis (LC), which had been treated with
diuretics and branched-chain amino acids for the past 3
months. He had been taking approximately 100g of alco-
hol per day for more than 30 years with a balanced diet.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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as follows: total bilirubin, 1.36mg/dL; albumin, 3.5g/dL;
and international normalized ratio, 1.05. In addition, he
had mild ascites, which was medically controlled. These
findings were indicative of Child-Pugh class B LC. A
gastrointestinal endoscopy had been performed the pre-
vious month, but it did not detect any esophageal or
gastric varices. In addition, he had not had any episodes
of hematemesis or produced bloody stools. On arrival,
he appeared to be disturbed and distressed and was clas-
sified as 13 (E3V4M6) on the Glasgow Coma Scale. His
vital signs were as follows: respiratory rate, 30 breaths/
minute; pulse rate, 147 beats/minute and regular; blood
pressure, 64/34mmHg; and temperature, 38.4°C. He did
not have a headache; sore throat; cough; sputum; or
chest, abdominal, or back pain. Auscultation of his lungs
and heart produced normal findings. His abdomen was
soft and flat and non-tender, and no skin rashes or infec-
tious wounds were present on his extremities. Arterial
blood gas analysis detected severe lactic acidosis (lactate
concentration: 18mmol/L), which was indicative of sep-
tic shock (Table 1). Rapid fluid resuscitation with ad-
equate doses of vitamin B administration was started
immediately followed by tracheal intubation and mech-
anical ventilation according to the goal-oriented therapy
protocol. Empirical antimicrobial treatment with mero-
penem and teicoplanin was administered 20 minutes
after his arrival, and two sets of blood cultures were ob-
tained at the same time. His laboratory data were indica-
tive of multiple organ failure; that is, pancytopenia,
coagulopathy, and acute kidney injury were detectedTable 1 The patient’s arterial blood gas analysis and data fin

















ALT, alanine transaminase; APTT, activated partial thromboplastin time; AST, asparta
CRP, C-reactive protein; D-Bil, direct bilirubin; HCO3, bicarbonate; Hct, hematocrit; H
PaCO2, carbon dioxide partial pressure arterial; PaO2, oxygen partial pressure arteria
protein; WBC, white blood cell count.together with high levels of procalcitonin and endo-
toxins (Table 1). However, a whole body computed tom-
ography scan did not identify an infection focus. On
admission to the emergency intensive care unit (EICU),
his Acute Physiology and Chronic Health Evaluation
(APACHE II) score was 32, and his Sequential Organ
Failure Assessment (SOFA) score was 16. Because he ex-
hibited persistent catecholamine-resistant hypotension,
endotoxin absorption therapy based on polymyxin B
hemoperfusion (PMX) and cytokine-absorption therapy
involving the use of a polymethylmethacrylate (PMMA)
membrane hemofilter were performed to counteract his
multiple organ failure. Other supportive treatments for
his refractory shock such as the infusion of immuno-
globulins, methylprednisolone, and recombinant human
soluble thrombomodulin (rhTM) were also initiated. The
level of fluid resuscitation was adjusted to maintain his
urinary output at 0.5 to 1.0mL/kg/hour (Figure 1), and
he was transfused with 6, 14, and 30 units of red cell
concentrate, fresh frozen plasma, and platelet concentrate,
respectively, within the first 24 hours after his admission.
The initial resuscitative treatments resulted in a reduction
in his lactate and endotoxin level and the maintenance of
his mean blood pressure above 65mmHg. Ongoing aggres-
sive critical care led to a gradual tapering of the catechol-
amine dose and an improvement in his SOFA score
(Figure 2). An examination of his blood culture detected
A. hydrophila, so, based on the results of sensitivity tests,
we replaced the meropenem and teicoplanin with ceftazi-
dime. We finally diagnosed him with spontaneous A.
hydrophila septicemia combined with refractory shockdings on admission















te transaminase; AT3, antithrombin 3; BUN, blood urea nitrogen; Cl, chlorine;
gb, hemoglobin; INR, international normalized ratio; K, potassium; Na, sodium;
































Figure 1 Patient’s clinical course during the first 12 hours after
his arrival. DBP, diastolic blood pressure; MEPM, meropenem;
PMMA, polymethylmethacrylate; PMX, polymyxin B hemoperfusion;
SBP, systolic blood pressure; TEIC, teicoplanin.
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day 10, he was successfully extubated, and he was dis-
charged from the EICU the next day. Antibiotics were ad-
ministered for 2 weeks. The patient was transferred to a
satellite hospital to continue his rehabilitation on day 19.
Discussion
The mortality rate of severe sepsis with or without shock
in the intensive care setting is very high (about 23%) [6],
and evidence-based recommendations have been pub-
lished with the aim of improving the outcomes of severe
sepsis and septic shock in critically ill patients [4,7]. Se-
vere sepsis and septic shock are associated with signifi-
cantly higher mortality in cirrhotic patients than in non-
cirrhotic patients [8]. The most common bacterial infec-
tions seen in cirrhotic patients are spontaneous bacterial
peritonitis (25 to 31%), urinary tract infections (20 to
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Figure 2 The patient’s clinical course over the first 7 days after
his admission. CAZ, ceftazidime; CRP, C-reactive protein; MEPM,
meropenem; mPSL, methylprednisolone; PCT, procalcitonin; PMMA,
polymethylmethacrylate; PMX, polymyxin B hemoperfusion; SOFA,
Sequential Organ Failure Assessment; TEIC, teicoplanin; WBC, white
blood cell count.tissue infections (11%), and the most common causative
organisms of such infections are Staphylococcus species,
Enterococcus species, and methicillin-resistant Staphylo-
coccus aureus among Gram-positive bacteria and
Escherichia coli, Klebsiella species, and Enterobacter
species among Gram-negative bacteria. Other bacterial
infections such as those involving Vibrio species, Aero-
monas species, Clostridium species, and Mycobacterium
tuberculosis are more virulent [3,9]. Aeromonas species
cause a variety of diseases including acute gastroenteritis,
skin and soft tissue infections, and septicemia. Aeromonas
septicemia is strongly associated with immunosuppressive
conditions such as cirrhosis and hematological ma-
lignancies. Among the various Aeromonas species, A.
hydrophila is the most commonly identified pathogen
[1,2,10]. Bacterial translocation is associated with the
pathogenesis of spontaneous bacterial peritonitis and
spontaneous bacteremia in cirrhotic patients. In the
present case, as the patient had no trauma episodes or
wound site, oral transmission was the probable cause of
infection pathway. The intravenous administration of
carbapenems or third generation cephalosporins com-
bined with aminoglycosides or fluoroquinolones is rec-
ommended as an empiric treatment for serious bacterial
infections in cirrhotic patients [3]. In the present case,
the early recognition of septic shock and the initiation
of rapid resuscitation techniques including the adminis-
tration of antimicrobials were considered to be the most
important factors in the saving of our patient’s life. It is
reported that delaying antibiotic treatment until after
the identification of shock is associated with a worse
prognosis [11]. Various kinds of treatment have been
used to treat severe sepsis and septic shock. For in-
stance, direct hemoperfusion with PMX is suggested to
have favorable effects on blood pressure, oxygenation,
and mortality [12], and hemoperfusion using PMMA
membrane hemofilters, which have an enhanced ability
to absorb cytokines, might improve the mortality rate of
such conditions [13]. In addition, the early infusion of
stress dose steroids should be considered in patients
with septic shock whose blood pressure issues are
poorly responsive to fluid resuscitation and catechol-
amine [7], and the administration of rhTM might be ef-
fective at treating sepsis-induced coagulopathy [14].
Although further investigations are required to confirm
whether such supportive therapies are effective, aggres-
sive treatment with multiple modalities and combined
therapies could be effective in patients with severe sep-
tic shock who are unresponsive to conventional man-
agement strategies.
Conclusions
We described a case of septic shock due to A. hydro-
phila bacteremia in a patient with LC. In addition to the
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resuscitation techniques including the administration of
antimicrobials, aggressive multidisciplinary intensive
care resulted in the successful treatment of our patient’s
septic shock.
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